Otsuka Holdings
4578.T
#649
Rank
โ‚น3.759 T
Marketcap
โ‚น7,167
Share price
1.79%
Change (1 day)
45.43%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2026 (TTM): โ‚น307.78

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is โ‚น340.89. In 2025 the company made an earnings per share (EPS) of โ‚น423.83 an increase over its 2024 EPS that were of โ‚น390.64.

EPS history for Otsuka Holdings from 2009 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น307.78-27.38%
2025โ‚น423.838.5%
2024โ‚น390.64153.9%
2023โ‚น153.85-15.71%
2022โ‚น182.53-6.18%
2021โ‚น194.54-24.1%
2020โ‚น256.3322.95%
2019โ‚น208.4856.13%
2018โ‚น133.53-25.11%
2017โ‚น178.3125.99%
2016โ‚น141.53-6.37%
2015โ‚น151.17
2014N/A-100%
2013โ‚น227.7618.06%
2012โ‚น192.911.01%
2011โ‚น190.9729.07%
2010โ‚น147.96-94.47%
2009โ‚น2,675